Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT03493711 Active, not recruiting - Healthy Clinical Trials

Differences Between Breastfed and Formula Fed Infants

Start date: February 21, 2018
Phase:
Study type: Observational

This study will help us learn how a child's diet affects growth and development.

NCT ID: NCT03472820 Active, not recruiting - Healthy Clinical Trials

Methylation Diet and Lifestyle Study

MDL
Start date: February 1, 2018
Phase: N/A
Study type: Interventional

The maintenance of health and the progression of disease are associated with an individual's genetic make-up and environmental factors, including lifestyle choices (such as diet, exercise, behaviors, stressors, sleep, tobacco and alcohol use), environmental exposures and socioeconomic determinants. Environmental factors have been shown to influence, sometimes rapidly, epigenetic processes thereby influencing genetic expression. Regulation of the human genome by the epigenome is now regarded as a cornerstone, heritable, physiologic process, playing a key role in phenotypic expression of health and disease. DNA methylation is a well-researched, primary epigenetic process. Aberrant DNA methylation resulting in hyper- or hypomethylated regions of the genome, generally results in inhibition or expression of certain genes and has been associated with the pathogenesis of numerous conditions, ranging from inflammation and accelerated aging, to cancer, autoimmunity, diabetes, heart disease, dementia, allergic disease, posttraumatic stress disease and others. Likewise, certain healthy diet and lifestyle habits have been demonstrated to favorably influence DNA methylation patterns. Understanding that environmental factors can potently and sometimes rapidly, favorably or negatively influence epigenetic expression, a short-term diet and lifestyle intervention may significantly augment DNA methylation expression. The purpose of this study is to evaluate a 9-week diet and lifestyle intervention on patient-reported quality of life, symptoms, and DNA and biochemical methylation-related biomarkers in healthy males ages 50-72.

NCT ID: NCT03452111 Active, not recruiting - Healthy Clinical Trials

Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception

Start date: October 25, 2018
Phase: Phase 2
Study type: Interventional

The long term objective is to develop a gel to be used as a male contraceptive.

NCT ID: NCT03437681 Active, not recruiting - Healthy Clinical Trials

Tissue-specific Effects of Insufficient Sleep

Start date: February 12, 2018
Phase: N/A
Study type: Interventional

This study plans to learn more about how sleep loss impacts the way the body responds to sugar. This work will have important implications for development of treatments and countermeasures for people who are not able to get enough sleep for various reasons.

NCT ID: NCT03430726 Active, not recruiting - Healthy Clinical Trials

ProbGut: Probiotics on the Healthy Gut Microbiota

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

In adults, probiotics have been shown to have no effect on the microbial composition and the beneficial effects are only transient. However, the gut microbiota of young children is less stable and more impressionable. The aim of this study is to examine the effects of probiotics on the developing microbiota in early life and to determine whether a young child's microbiota may be less resilient to probiotic-induced changes and possibly resulting in longer lasting probiotic effects compared to adults.

NCT ID: NCT03429946 Active, not recruiting - Healthy Clinical Trials

Hypoglycemia and Autonomic Nervous System Function-B

HypoANS-B
Start date: July 17, 2013
Phase: Phase 4
Study type: Interventional

This study tests the hypothesis that, compared to prior normal blood sugar, prior low blood sugar impairs cardiovascular autonomic function. The proposed studies will also test the hypothesis that the effects of prior low blood sugar on cardiovascular autonomic function are blocked by administration of a mineralocorticoid receptor antagonist.

NCT ID: NCT03406351 Active, not recruiting - Healthy Clinical Trials

Air Pollution, Asthma and Circadian Clocks

APACC
Start date: January 15, 2018
Phase:
Study type: Observational

Societies become increasingly urban - more than half the world's population now lives in cities. Urbanization elevates anthropogenic (man-made) exposure to air pollutants. A clear association exists between exposure to air pollutants and exacerbations (worsening) of pre-existing asthma, incidence of nighttime asthma, difficulties with asthma control and increased disease risk. In 2012, the Public Health Management Corporation's Community Health Data Base estimated that 19.4% of adults in Philadelphia had asthma compared to a national prevalence of 7%. Asthma has a clear temporal signal. A majority of asthma patients, up to 75%, reports nighttime awakenings due to worsened cough, wheeze and dyspnea. This time-of-day-dependent exacerbation of symptoms, coined nocturnal asthma, is associated with poorer disease control, more frequent medication, and higher asthma-related morbidity and mortality. Consequently, several pathophysiological mechanisms proposed for nocturnal asthma relate to circadian clock biology. Lung function oscillates over the course of 24 hours, peaking around noon and reaching its nadir during early morning hours. Concentrations of air pollutants show oscillating patterns in urban settings. In this clinical research study, the investigators start to address how spatiotemporal fluctuations in air pollutants relate to asthma. Mechanistically, the investigators wish to address the hypothesis that microRNAs (miRs) act as interface between asthma phenotypes, circadian clocks and environmental exposure.

NCT ID: NCT03401320 Active, not recruiting - Healthy Clinical Trials

Evaluation of IM Letrozole ISM® Pharmacokinetics, Safety, and Tolerability in Healthy Post-menopausal Women (LISA-1)

Start date: November 6, 2017
Phase: Phase 1
Study type: Interventional

This is a Phase I, open label, dose escalation study designed to evaluate the pharmacokinetics, safety, and tolerability of single intramuscular injections of Letrozole ISM® at different strengths in voluntary healthy post menopausal women

NCT ID: NCT03386396 Active, not recruiting - Healthy Clinical Trials

Brain Fuel - Morning Nutrition and Cognitive Function

Start date: November 28, 2017
Phase: N/A
Study type: Interventional

This study will help us learn more about how what a child eats can affect how their brain works.

NCT ID: NCT03321318 Active, not recruiting - Healthy Clinical Trials

AK-R215 Pharmacokinetic Study Phase I

Start date: July 13, 2017
Phase: Phase 1
Study type: Interventional

An open label, randomized, 2-sequence, 2-period, single-dose cross-over study to evaluate the pharmacokinetics characteristics of AK-R215